Heyue Zhou

This inventor holds 62 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Antibody Therapeutics (CPC class C07K). Top assignees: Sorrento Therapeutics, Inc., Vivasor, Inc., Jmb Capital Partners Lending, LLC. Active years: 2014-2026.

USPTO Granted Patents = 62 (Patent Applications = 17)

% Patents Active = 87.1

CIPO Patents = 4 (Patent Applications = 30)

EPO Patents = 9 (Patent Applications = 42)

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 290(Granted Patents)

Forward Citations (Not Self Cited) = 252(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

56 out of 114

Sorrento Therapeutics, Inc.

Jmb Capital Partners Lending, LLC

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Antibody

CD38

PD-L1

VEGFR2

Cancer Treatment

Binding Proteins

Chimeric Antigen Receptor

Therapeutics

Anti-KRAS

CTLA4

JAG1

CCR2

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734209 - CD38 Antibody Drug Conjugate (2026-09-15),

2. 12630642 - Antigen Binding Proteins that Bind BCMA (2026-05-19),

3. 12624103 - Engineered Antibodies That Bind LAG3 (2026-05-12),

4. 12600790 - Variant Antibody That Binds Cd38 (2026-04-14),

5. 12084503 - Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment (2024-09-10),

6. 11999792 - Antibody therapeutics that bind CD38 (2024-06-04),

7. 11919952 - Antigen binding proteins that bind PD-L1 (2024-03-05),

8. 11878058 - Antigen binding proteins that bind PD-L1 (2024-01-23),

9. 11760806 - CD-38 directed chimeric antigen receptor constructs (2023-09-19),

10. 11746156 - Antibody therapeutics that bind CD123 (2023-09-05),

11. 11318202 - Antigen binding proteins that bind WISP1 (2022-05-03),

12. 11242391 - Antigen binding proteins that bind PD-1 (2022-02-08),

13. 11191845 - CD38 antibody drug conjugate (2021-12-07),

14. 11180568 - Antibody therapeutics that bind CD137 (2021-11-23),

15. 11174314 - Anti-KRAS binding proteins (2021-11-16),

Title: Inventor Heyue Zhou - Revolutionizing Technology in San Diego

Introduction: Heyue Zhou is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Heyue Zhou holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Heyue Zhou has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Heyue Zhou has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: Heyue Zhou's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in San Diego and beyond.